Elite Pharmaceuticals's total assets for Q4 2025 were $96.39M, an increase of 6.20% from the previous quarter. ELTP total liabilities were $42.87M for the fiscal quarter, a -21.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.